Related Experiment Video

Updated: May 6, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

26.8K

[Endothelium-dependent and endothelium-independent vasodilation in patients with chronic prostatitis]

A A Polunin, V M Miroshnikov, L P Voronina

    Urologiia (Moscow, Russia : 1999)
    |October 29, 2013
    PubMed

    Insights

    Chronic prostatitis impairs microvascular function, showing reduced blood flow and endothelial vasomotor activity in affected men. This suggests compromised microvasculature capacity in both bacterial and abacterial prostatitis.

    Area of Science:

    • Urology
    • Vascular Biology
    • Microcirculation Research

    Context:

    • Chronic prostatitis affects numerous men of reproductive age.
    • Understanding microvascular dysfunction is crucial for managing chronic prostatitis.
    • Endothelial function plays a key role in vascular health.

    Purpose:

    • To evaluate basal blood flow in men with chronic prostatitis using laser Doppler flowmetry.
    • To assess endothelial vasomotor function via ionophoretic tests.
    • To investigate microvascular reserve capacity in chronic prostatitis patients.

    Summary:

    • Laser Doppler flowmetry revealed altered basal blood flow in chronic prostatitis patients.
    • Ionophoretic tests with acetylcholine and sodium nitroprusside indicated impaired endothelial vasomotor function.
    • Results suggest a decreased microvasculature reserve capacity in chronic prostatitis, irrespective of etiology (bacterial or abacterial).

    Impact:

    • Highlights potential microvascular contributions to chronic prostatitis pathophysiology.
    • Suggests impaired microvascular function as a commonality in chronic prostatitis.
    • Provides insights for potential therapeutic targets aimed at improving microvascular health in prostatitis.

    More Related Videos

    Assessing Endothelial Vasodilator Function with the Endo-PAT 200007:46

    Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

    Published on: October 15, 2010

    45.2K
    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology09:33

    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

    Published on: February 7, 2015

    19.6K

    Related Concept Videos

    Antihypertensive Drugs: Vasodilators01:23

    Antihypertensive Drugs: Vasodilators

    Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
    2.5K
    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

    Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

    Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
    Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
    842
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    618
    Acute Inflammation II: Local and Systemic Effects01:25

    Acute Inflammation II: Local and Systemic Effects

    Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
    84
    Nitric Oxide Signaling Pathway01:28

    Nitric Oxide Signaling Pathway

    Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
    5.3K
    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

    Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
    ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
    619